Ali Cheema
Family Medicine · Nicholasville, KYNPI 1184942765
Payments from drug & device makers
Across 100 payments — averaging $14.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$535
- Lilly USA, LLC$142
- GSK$109
- Pfizer$105
- Amgen$77
- Novo Nordisk$63
- plus $463 from 18 others
What the payments were for
- Food & beverage$1,495100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $535 |
| Lilly USA, LLC | 9 | $142 |
| GSK | 7 | $109 |
| Pfizer | 7 | $105 |
| Amgen | 5 | $77 |
| Novo Nordisk | 4 | $63 |
| Hologic Sales And Service, LLC | 2 | $57 |
| Astellas Pharma US Inc | 2 | $46 |
| Amarin Pharma, Inc. | 3 | $41 |
| AstraZeneca | 3 | $40 |
| Sanofi-aventis U.S. LLC | 2 | $34 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $29 |
| Esperion Therapeutics, Inc. | 2 | $27 |
| Novartis | 2 | $23 |
| Biogen | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Amryt Pharma Holdings Ltd | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Medtronic | 1 | $12 |
How this compares
$1,495 in reported general payments places this provider in the 60th percentile of 1,559 family medicine providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 25 | $31,104 |
| JanuviaSitagliptin Phosphate | 20 | $22,266 |
| EliquisApixaban | 16 | $11,702 |
| OzempicSemaglutide | 11 | $11,112 |
| VascepaIcosapent Ethyl | 17 | $8,144 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $2,404 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 26 | $940 |
| Nifedipine ErNifedipine | 36 | $829 |
| Atorvastatin Calcium | 87 | $620 |
| Losartan Potassium | 60 | $473 |
| Rosuvastatin Calcium | 30 | $366 |
| Levothyroxine Sodium | 51 | $338 |
| Pantoprazole Sodium | 44 | $336 |
| Amlodipine Besylate | 57 | $314 |
| Pravastatin Sodium | 45 | $306 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $105 | $11,70216 claims |
| Novo NordiskOzempic | $63 | $11,11211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Nicholasville
- Brian SmithVersailles$7.7M
- Barbara Fleming-PhillipsLexington$1.4M
- Christopher RhyneLouisville$1M
- Kruti PatelBurlington$463K
- Michael LovelaceLouisville$244K
- John RichardLexington$226K
- Diego MastronardiBowling Green$196K
- James TurnboPaducah$124K
- Eleida Tur OlivaLexington$113K
- Jeffrey GreenParis$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.